PEPTONIC medical AB (publ)

DB:28L Stock Report

Market Cap: €29.6m

PEPTONIC medical Balance Sheet Health

Financial Health criteria checks 2/6

PEPTONIC medical has a total shareholder equity of SEK85.2M and total debt of SEK12.2M, which brings its debt-to-equity ratio to 14.3%. Its total assets and total liabilities are SEK123.4M and SEK38.2M respectively.

Key information

14.3%

Debt to equity ratio

SEK 12.20m

Debt

Interest coverage ration/a
CashSEK 1.83m
EquitySEK 85.18m
Total liabilitiesSEK 38.18m
Total assetsSEK 123.35m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 28L's short term assets (SEK59.8M) exceed its short term liabilities (SEK38.2M).

Long Term Liabilities: 28L's short term assets (SEK59.8M) do not cover its long term liabilities (SEK-1,000.0).


Debt to Equity History and Analysis

Debt Level: 28L's net debt to equity ratio (12.2%) is considered satisfactory.

Reducing Debt: 28L's debt to equity ratio has increased from 0% to 14.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 28L has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 28L has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.7% each year


Discover healthy companies